Clinical trial
Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
NCT06793228
Study timeline
Study start (estimated)2025-01-15Date precision: day
Registry last updated2025-01-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
SCLC, Extensive Stageunresolved
Interventions
Sponsors & collaborators
Henan Cancer Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06793228 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.